Bide Pharmatech Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	117.43	109.57	145.97	97.57
Depreciation & Amortization	28.43	26.93	17.61	10.67
Other Amortization	15.25	14.16	8.62	7.47
Loss (Gain) From Sale of Assets	-0.86	-0.44	-	-7.92
Asset Writedown & Restructuring Costs	0.03	0	0	0.04
Loss (Gain) From Sale of Investments	-5.98	8.87	0.4	-0.41
Provision & Write-off of Bad Debts	1.75	4.33	3.52	3.06
Other Operating Activities	41.23	20.11	-5.92	11.97
Change in Accounts Receivable	10.05	-45.02	-74.5	-58.02
Change in Inventory	-96.65	-196.27	-52.81	-267.2
Change in Accounts Payable	43.2	-1.58	-14.89	134.92
Change in Other Net Operating Assets	1.69	12.32	-	1.99
Operating Cash Flow	158.31	-57.39	29.87	-64.88
Capital Expenditures	-88.35	-61.08	-38.41	-29.2
Sale of Property, Plant & Equipment	2.2	0.93	-	15.15
Investment in Securities	-77.92	-	0.59	43.41
Other Investing Activities	5.59	4.06	-4.79	-
Investing Cash Flow	-158.48	-28.87	-42.61	29.36
Short-Term Debt Issued	97.35	0.23	-	20.73
Long-Term Debt Issued	5.6	4.98	9.61	-
Total Debt Issued	102.94	5.21	9.61	20.73
Short-Term Debt Repaid	-68.01	-9.53	-	-37.69
Long-Term Debt Repaid	-21.88	-21.83	-13.89	-8.53
Total Debt Repaid	-89.89	-31.36	-13.89	-46.22
Net Debt Issued (Repaid)	13.06	-26.14	-4.28	-25.49
Issuance of Common Stock	-	-	1,335	163.9
Repurchase of Common Stock	-100.02	-	-	-
Common Dividends Paid	-79.88	-100.03	-0.08	-0.19
Other Financing Activities	-	-12.13	-20.52	-0.77
Financing Cash Flow	-166.84	-138.31	1,310	137.44
Foreign Exchange Rate Adjustments	-1.44	-5.83	4.73	-0.3
Net Cash Flow	-168.45	-230.39	1,302	101.62
Free Cash Flow	69.97	-118.47	-8.54	-94.09
Free Cash Flow Margin	6.35%	-10.85%	-1.02%	-15.52%
Free Cash Flow Per Share	0.79	-1.31	-0.12	-1.41
Cash Income Tax Paid	19.77	2.5	25.48	12.74
Levered Free Cash Flow	26.94	-188.91	-43.78	-120.54
Unlevered Free Cash Flow	29.01	-187.33	-42.42	-119.96
Change in Working Capital	-38.96	-240.92	-140.34	-187.34

Source: S&P Global Market Intelligence. Standard template. Financial Sources.